Skip to content
PubMed This is a summary of 58 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 58 referenced papers

Top Authors

Jacinta C. Bustamante
Hôpital Necker-Enfants Malades
Jean‐Laurent Casanova
Hôpital Necker-Enfants Malades
Satoshi Okada
Hiroshima University
Anne Puel
Hôpital Necker-Enfants Malades
Jérémie Rosain
Hôpital Necker-Enfants Malades
Mélanie Migaud
Hôpital Necker-Enfants Malades
Seyed Alireza Mahdaviani
Masih Daneshvari Hospital
Rubén Martínez‐Barricarte
Rockefeller University
Brigitte Glanzmann
South African Medical Research Council

Top Institutions

Ranked by publications Top 10 institutions

References

References (58)
  1. 1

    IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations.

    Okada S, Markle JG, Deenick EK, et al.

    Science (New York, N.Y.) 2015; (349(6248)):606-613 doi:10.1126/science.aaa4282.

    PMID: 26160376
  2. 2

    Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations.

    Lee PP

    Annals of the Academy of Medicine, Singapore 2015; (44(8)):297-301.

    PMID: 26477962
  3. 3

    Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

    Nahid P, Dorman SE, Alipanah N, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016; (63(7)):853-67 doi:10.1093/cid/ciw566.

    PMID: 27621353
  4. 4

    Disseminated bacille Calmette-Guérin disease in Saudi children: clinical profile, microbiology, immunology evaluation and outcome.

    Bukhari E, Alaklobi F, Bakheet H, et al.

    European review for medical and pharmacological sciences 2016; (20(17)):3696-702.

    PMID: 27649674
  5. 5

    Vaccination in Primary Immunodeficiency Disorders.

    Sobh A, Bonilla FA

    The journal of allergy and clinical immunology. In practice 2016; (4(6)):1066-1075 doi:10.1016/j.jaip.2016.09.012.

    PMID: 27836056
  6. 6

    Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity.

    Okada S, Puel A, Casanova JL, Kobayashi M

    Clinical & translational immunology 2016; (5(12)):e114 doi:10.1038/cti.2016.71.

    PMID: 28090315
  7. 7

    Clinical and genetic features of IL12Rb1 deficiency: Single center experience of 18 patients.

    Tan Ç, Çağdaş-Ayvaz D, Metin A, et al.

    The Turkish journal of pediatrics 2016; (58(4)):356-361 doi:10.24953/turkjped.2016.04.002.

    PMID: 28276206
  8. 8

    RORγt and RORα signature genes in human Th17 cells.

    Castro G, Liu X, Ngo K, et al.

    PloS one 2017; (12(8)):e0181868 doi:10.1371/journal.pone.0181868.

    PMID: 28763457
  9. 9

    Oesophageal candidiasis and squamous cell cancer in patients with gain-of-function STAT1 gene mutation.

    Koo S, Kejariwal D, Al-Shehri T, et al.

    United European gastroenterology journal 2017; (5(5)):625-631 doi:10.1177/2050640616684404.

    PMID: 28815025
  10. 10

    Measurement and Estimation of Glomerular Filtration Rate in Children.

    Mian AN, Schwartz GJ

    Advances in chronic kidney disease 2017; (24(6)):348-356 doi:10.1053/j.ackd.2017.09.011.

    PMID: 29229165
  11. 11

    A 25-year surveillance of disseminated Bacillus Calmette-Guérin disease treatment in children in Southern Iran.

    Amanati A, Pouladfar G, Kadivar MR, et al.

    Medicine 2017; (96(52)):e9035 doi:10.1097/MD.0000000000009035.

    PMID: 29384896
  12. 12

    Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.

    Esteve-Solé A, Sologuren I, Martínez-Saavedra MT, et al.

    Critical reviews in clinical laboratory sciences 2018; (55(3)):184-204 doi:10.1080/10408363.2018.1444580.

    PMID: 29502462
  13. 13

    Mendelian susceptibility to mycobacterial disease: 2014-2018 update.

    Rosain J, Kong XF, Martinez-Barricarte R, et al.

    Immunology and cell biology 2019; (97(4)):360-367 doi:10.1111/imcb.12210.

    PMID: 30264912
  14. 14

    Evaluation of interleukin-12 receptor β1 and interferon gamma receptor 1 deficiency in patients with disseminated BCG infection.

    Pourakbari B, Hosseinpour Sadeghi R, Mahmoudi S, et al.

    Allergologia et immunopathologia 2019; (47(1)):38-42 doi:10.1016/j.aller.2018.06.005.

    PMID: 30268380
  15. 15

    A Syrian Refugee in Iraq Diagnosed as a Case of IL12RB1 Deficiency in Japan Using Dried Blood Spots.

    Al-Kzayer LFY, Yassin AK, Salih KH, et al.

    Frontiers in immunology 2019; (10()):58 doi:10.3389/fimmu.2019.00058.

    PMID: 30740107
  16. 16

    Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.

    Pöyhönen L, Bustamante J, Casanova JL, et al.

    Journal of clinical immunology 2019; (39(4)):376-390 doi:10.1007/s10875-019-00642-3.

    PMID: 31123910
  17. 17

    Safety and tolerability of moxifloxacin for the treatment of disseminated BCGitis in children.

    Alsuhaibani M, Felimban G, Shoukri M, et al.

    International journal of pediatrics & adolescent medicine 2019; (6(2)):47-50 doi:10.1016/j.ijpam.2019.01.003.

    PMID: 31388545
  18. 18

    The application of HPLC/MS analysis with a multi-enzyme digest strategy to characterize different interferon product variants produced from Pichia pastoris.

    Wang Y, Liu D, Crowell LE, et al.

    Amino acids 2019; (51(9)):1353-1363 doi:10.1007/s00726-019-02772-9.

    PMID: 31446487
  19. 19

    DISSEMINATED BACILLUS-CALMETTE-GUÉRIN INFECTIONS AND PRIMARY IMMUNODEFICIENCY DISORDERS IN SINGAPORE: A SINGLE CENTER 15-YEAR RETROSPECTIVE REVIEW.

    Ong RYL, Chan SB, Chew SJ, et al.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2020; (97()):117-125 doi:10.1016/j.ijid.2020.05.117.

    PMID: 32497805
  20. 20

    Spectrum of Inborn errors of immunity in a cohort of 90 patients presenting with complications to BCG vaccination in India.

    Yadav RM, Dalvi A, Gupta M, et al.

    Scandinavian journal of immunology 2021; (93(5)):e13010 doi:10.1111/sji.13010.

    PMID: 33325540
  21. 21

    [Disseminated infection caused by the bacillus Calmette-Guérin vaccine and SARS-CoV-2 coinfection in a patient with IL-12 receptor β1 subunit deficiency].

    Allen-Manzur JG, Espinosa-Padilla SE, Bustamante J, et al.

    Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 2020; (67(4)):401-407 doi:10.29262/ram.v67i4.798.

    PMID: 33631907
  22. 22

    Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.

    Zhang W, Chen X, Gao G, et al.

    Frontiers in immunology 2021; (12()):654406 doi:10.3389/fimmu.2021.654406.

    PMID: 33777053
  23. 23

    Development of a Multiplex Real-Time PCR Assay for Mycobacterium bovis BCG and Validation in a Clinical Laboratory.

    Duffy SC, Venkatesan M, Chothe S, et al.

    Microbiology spectrum 2021; (9(2)):e0109821 doi:10.1128/Spectrum.01098-21.

    PMID: 34494864
  24. 24

    Phenotypic and immune functional profiling of patients with suspected Mendelian Susceptibility to Mycobacterial Disease in South Africa.

    van Coller A, Glanzmann B, Cornelissen H, et al.

    BMC immunology 2021; (22(1)):62 doi:10.1186/s12865-021-00452-6.

    PMID: 34517836
  25. 25

    Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo.

    Saenz SA, Local A, Carr T, et al.

    PloS one 2021; (16(11)):e0248034 doi:10.1371/journal.pone.0248034.

    PMID: 34752458
  26. 26

    Mendelian susceptibility to mycobacterial disease in tuberculosis-hyperendemic South Africa.

    Cornelissen HM, Glanzmann B, Van Coller A, et al.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2021; (111(10)):998-1005 doi:10.7196/SAMJ.2021.v111i10.15341.

    PMID: 34949297
  27. 27

    Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD): a case series.

    Mahdaviani SA, Fallahi M, Jamee M, et al.

    Annals of clinical microbiology and antimicrobials 2022; (21(1)):8 doi:10.1186/s12941-022-00500-y.

    PMID: 35232430
  28. 28

    Immunizing the imperfect immune system: Coronavirus disease 2019 vaccination in patients with inborn errors of immunity.

    Durkee-Shock JR, Keller MD

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2022; (129(5)):562-571.e1 doi:10.1016/j.anai.2022.06.009.

    PMID: 35718282
  29. 29

    Mendelian Susceptibility to Mycobacterial Diseases (MSMD) in a 13-Year-Old Ethiopian Girl with Autosomal Dominant Interferon Gamma Receptor 1(IFN-γ R1) Defect: A Clinical Diagnostic and Treatment Challenge.

    Gebeyehu NA, Deribessa SJ, Alexandra F, et al.

    Case reports in infectious diseases 2022; (2022()):6534009 doi:10.1155/2022/6534009.

    PMID: 36193331
  30. 30

    An Updated Review on MSMD Research Globally and A Literature Review on the Molecular Findings, Clinical Manifestations, and Treatment Approaches in China.

    Xia L, Liu XH, Yuan Y, et al.

    Frontiers in immunology 2022; (13()):926781 doi:10.3389/fimmu.2022.926781.

    PMID: 36569938
  31. 31

    Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds.

    Errami A, Baghdadi JE, Ailal F, et al.

    Journal of clinical immunology 2023; (43(4)):728-740 doi:10.1007/s10875-022-01419-x.

    PMID: 36630059
  32. 32

    Autosomal dominant chronic mucocutaneous candidiasis with STAT1 mutation can be associated with chronic active hepatitis: A case report.

    Liu L, Huang Y, Liao Y, Shu S

    Frontiers in pediatrics 2022; (10()):990729 doi:10.3389/fped.2022.990729.

    PMID: 36683786
  33. 33

    [Recommendations for care, prevention of infections and chemoprophylaxis in inborn errors of immunity].

    Villa M, Merhar C, Nievas E, et al.

    Archivos argentinos de pediatria 2023; (121(1)):e202202885 doi:10.5546/aap.2022-02885.

    PMID: 36701243
  34. 34

    Fatal Severe Cytokine Release Syndrome Post-haploidentical Stem Cell Transplant With Post-transplant Cyclophosphamide in an Infant With Severe Combined Immunodeficiency and Disseminated Bacille Calmette-Guérin Infection.

    Arora S, Upasana K, Thakkar D, et al.

    Journal of pediatric hematology/oncology 2023; (45(6)):e773-e774 doi:10.1097/MPH.0000000000002700.

    PMID: 37494614
  35. 35

    Disseminated BCG infection revealing a severe combined immunodeficiency: A case report.

    Ben Belgacem H, Bouguila J, Tej A, et al.

    La Tunisie medicale 2022; (100(12)):881-886.

    PMID: 37551538
  36. 36

    Mendelian susceptibility to mycobacterial diseases: State of the puzzle.

    Errami A, Bousfiha AA

    Qatar medical journal 2023; (2023(2)):25 doi:10.5339/qmj.2023.sqac.25.

    PMID: 38025345
  37. 37

    Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): A systematic review.

    Khavandegar A, Mahdaviani SA, Zaki-Dizaji M, et al.

    The Journal of allergy and clinical immunology 2024; (153(5)):1432-1444 doi:10.1016/j.jaci.2024.01.021.

    PMID: 38341181
  38. 38

    Recombinant IFN-γ1b Treatment in a Patient with Inherited IFN-γ Deficiency.

    Rosain J, Kiykim A, Michev A, et al.

    Journal of clinical immunology 2024; (44(3)):62 doi:10.1007/s10875-024-01661-5.

    PMID: 38363432
  39. 39

    Assistance of next-generation sequencing for diagnosis of disseminated Bacillus Calmette-Guerin disease with X-SCID in an infant: a case report and literature review.

    Zhang H, Liao Y, Zhu Z, et al.

    Frontiers in cellular and infection microbiology 2024; (14()):1341236 doi:10.3389/fcimb.2024.1341236.

    PMID: 38410723
  40. 40

    Mendelian Susceptibility to Mycobacterial Disease with Signal Peptide Peptidase-like 2A (SPPL2A) Deficiency: A Case Report.

    Esmaeilzadeh H, Pouladfar G, Gholami MA, Mohtadi H

    Iranian journal of allergy, asthma, and immunology 2024; (23(5)):588-593 doi:10.18502/ijaai.v23i5.16753.

    PMID: 39586751
  41. 41

    Clinical characteristics and genetic features of 35 cases of adverse reactions to Bacillus Calmette-Guérin vaccine in children.

    Chen H, Yang X, Huang Y, et al.

    Frontiers in cellular and infection microbiology 2025; (15()):1570382 doi:10.3389/fcimb.2025.1570382.

    PMID: 40470261
  42. 42

    Characteristics of patients with disseminated Bacillus Calmette-Guérin infection: a retrospective study at Namazi Hospital, Southern Iran, from 1991 to 2022.

    Sanaei Dashti A, Soflaee Shahrbabak S, Malekzadeh Y, et al.

    Journal of tropical pediatrics 2025; (71(4)) doi:10.1093/tropej/fmaf023.

    PMID: 40499196
  43. 43

    Clinical recommendations for diagnosis and management of Mendelian susceptibility to mycobacterial disease in resource-limited settings.

    Cornelissen H, Glanzmann B, van Coller A, et al.

    The journal of allergy and clinical immunology. Global 2025; (4(4)):100540 doi:10.1016/j.jacig.2025.100540.

    PMID: 41048447
  44. 44

    BCGitis and BCGosis: Clinical Spectrum, Immunological Mechanisms, and Risk Management.

    Liu Q, Dai X, Wei S

    Vaccines 2025; (13(12)) doi:10.3390/vaccines13121179.

    PMID: 41441645
  45. 45

    Case report: IL12RB1 deficiency in an infant with disseminated Bacille Calmette-Guérin disease.

    Ma X, Chen J, Cheng J, Wang J

    Frontiers in immunology 2025; (16()):1728612 doi:10.3389/fimmu.2025.1728612.

    PMID: 41668770
  46. 46

    What We Have Here Is a Failure to Communicate: Interleukin-12 / Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial Disease.

    Johnston AΜ, Rider NL, Freeman AF, et al.

    The journal of allergy and clinical immunology. In practice 2026; (14(7)):1529-1539 doi:10.1016/j.jaip.2026.02.026.

    PMID: 41786143
  47. 47

    Novel indications for hematopoietic stem cell transplantation in inborn errors of immunity.

    Laberko A, Gennery AR

    Expert review of clinical immunology 2026; (22(2)):183-193 doi:10.1080/1744666X.2026.2641540.

    PMID: 41786511
  48. 48

    Mendelian susceptibility to mycobacterial disease: Clinical, immunological, and genetic study in India.

    Dalvi A, Temkar L, Desai M, et al.

    Journal of human immunity 2026; (2(1)):e20250153 doi:10.70962/jhi.20250153.

    PMID: 42170591
  49. 49

    Mendelian susceptibility to mycobacterial disease: IFN-γ-driven immunity collapse underlies heterogeneous infections.

    Qian M, Zhou J, Zhou Q, et al.

    Frontiers in immunology 2026; (17()):1781297 doi:10.3389/fimmu.2026.1781297.

    PMID: 42183200
  50. 50

    Temporally Resolved Single-Cell RNA Sequencing Reveals Pathogenesis and Immune Responses in Intracerebral Bacille Calmette-Guérin (BCG) Infection.

    Xie S, Wang H, Huang S, et al.

    Pathogens (Basel, Switzerland) 2026; (15(5)) doi:10.3390/pathogens15050531.

    PMID: 42198657
  51. 51

    Inborn errors of immunity: a structured model for paediatric-to-adult transition of care.

    Civino A, Diomeda F, D'Orio C, et al.

    Frontiers in immunology 2026; (17()):1813944 doi:10.3389/fimmu.2026.1813944.

    PMID: 42199435
  52. 52

    Disseminated BCGosis in immunocompromised infants: a five-case series in the context of a national BCG vaccination policy change.

    Alhusaini W, Sanyour G, Kutbi R, et al.

    BMC pediatrics 2026; (26(1)).

    PMID: 42337472
  53. 53

    Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.

    Lawrence MG, Kim VHD, Orange JS, Scherzer R

    The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.

    PMID: 42447994
  54. 54

    Lymph Node Cytology Raising Suspicion for Evolving Secondary Hemophagocytic Lymphohistiocytosis in a Case of Mendelian Susceptibility to Mycobacterial Disease.

    Soni D, Mukhopadhyay S, Panwar H, et al.

    Diagnostic cytopathology 2026; (54(11)):E292-E295 doi:10.1002/dc.70186.

    PMID: 42483808
  55. 55

    Tailored conditioning for hematopoietic stem cell transplantation in children with Mendelian susceptibility to mycobacterial disease: A tale of two pathways for IFN-γ and IL-12 defects.

    Ganesan K, Balwani M, Seshadri N, et al.

    Journal of human immunity 2026; (2(5)):e20250264 doi:10.70962/jhi.20250264.

    PMID: 42516312
  56. 56

    Human inherited RORγT deficiency encompasses genetic heterogeneity, T cell deficiency, and clinical homogeneity.

    Fagniez I, Tsumura M, Guerin A, et al.

    medRxiv : the preprint server for health sciences 2026; doi:10.64898/2026.07.18.26358075.

    PMID: 42539146
  57. 57

    Persistent Ascites Revealing Mendelian Susceptibility to Mycobacterial Disease Due to IL-12Rβ1 Deficiency: A Case Report and Review of the Literature.

    Dolikhani M, Shakibamaram G, Rashtian P, et al.

    Case reports in immunology 2026; (2026()):3587297 doi:10.1155/crii/3587297.

    PMID: 42643649
  58. 58

    Pediatric Mycobacterium bovis Infection: Clinical Spectrum, BCG-Related Disease, Primary Immunodeficiency, and a Comprehensive Review of the Literature.

    Mete Atasever N, Dede E, Köksalan K, et al.

    Vaccines 2026; (14(10)) doi:10.3390/vaccines14100867.

    PMID: 42931396